NCT02478489View on ClinicalTrials.gov

Alcohol Disorder hOsPital Treatment Trial

PHASE4CompletedINTERVENTIONAL
Enrollment

248

Participants

Timeline

Start Date

June 30, 2016

Primary Completion Date

July 31, 2020

Study Completion Date

October 31, 2020

Conditions
Heavy DrinkingAlcohol DependenceAlcohol Use Disorder
Interventions
DRUG

Oral naltrexone (PO-NTX)

oral naltrexone

DRUG

Extended-release injectable naltrexone (XR-NTX)

injectable naltrexone

Trial Locations (1)

02118

Boston Medical Center, Boston

All Listed Sponsors
collaborator

National Institute on Alcohol Abuse and Alcoholism (NIAAA)

NIH

lead

Boston University

OTHER

NCT02478489 - Alcohol Disorder hOsPital Treatment Trial | Biotech Hunter | Biotech Hunter